All lobbying filings

ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)

Lobbying for ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.")

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $280,000.00 expenses · posted Apr 15, 2026

Official filing document

Bills named in this filing 5

S 4307
Protecting American Consumers from Robocalls Act
HR 2005
DMEPOS Relief Act of 2025
S 2951
Competitive Bidding Relief Act
HR 2902
SOAR Act of 2025
S 1406
SOAR Act of 2025

Lobbying activity 4

Health Issues

Issues related to patient access to home medical equipment and related reimbursement.

Medicare/Medicaid

Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Budget/Appropriations

FY 2027 Appropriations.

Veterans

CHAMPVA medical supply reimbursement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.